Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation

BACKGROUND: The epidermal growth factor receptor (EGFR) p.Thr790Met (T790M) mutation was discovered as a resistance mechanism in patients with lung cancer treated with first- and second-generation tyrosine kinase inhibitors. Further studies revealed the EGFR T790M mutation in treatment-naive non-sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagan, Olivia A., Rothstein, Anna, Jambunathan, Bhaghyasree, Hadziahmetovic, Mersiha, Antoniolli, Anita, Rashid, M. Hammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230275/
https://www.ncbi.nlm.nih.gov/pubmed/37265791
http://dx.doi.org/10.3389/fonc.2023.1176868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230275/
https://www.ncbi.nlm.nih.gov/pubmed/37265791
http://dx.doi.org/10.3389/fonc.2023.1176868

Ejemplares similares